Improvement of risk assessment in cutaneous melanoma (CM) by a prognostic 31-gene expression profile (31-GEP) test over AJCC-based staging alone. J of Skin [Internet]. 2018 Dec. 17 [cited 2025 Apr. 19];2:S70. Available from: https://skin.dermsquared.com/skin/article/view/466